BENEDETTI, LUANA
 Distribuzione geografica
Continente #
EU - Europa 1.393
Totale 1.393
Nazione #
IT - Italia 1.393
Totale 1.393
Città #
Vado Ligure 398
Genova 385
Genoa 371
Rapallo 222
Bordighera 17
Totale 1.393
Nome #
Dysimmune mononeuropathies: A diagnosis not to be missed 154
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 79
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. 74
Regional variation of Guillain-Barré syndrome 71
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 68
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 68
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 61
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series 57
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 53
I can’t count, but I can beat you playing cards: a case report on autoimmune encephalitis 49
Impact of environmental factors and physical activity on disability and quality of life in CIDP 48
null 48
ATYPICAL STIFF PERSON SYNDROME WITH ANTI-IGLON5 ANTIBODIES: A CASE REPORT 47
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 46
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 45
null 41
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 39
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 38
Are basketball players more likely to develop Hirayama disease? 38
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 36
Improving laboratory diagnostics in myasthenia gravis 31
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 25
Patients With Suspected Severe Adverse Reactions to COVID-19 Vaccination Admitted to Intensive Care Unit: A Case Report 24
An aggressive form of MOGAD treated with aHSCT: A case report 22
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 20
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 20
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 19
FDG-PET and ASL MRI identify largely overlapping hypermetabolic and hyperperfusion changes in limbic autoimmune encephalitis 18
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 15
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 14
Patient With Rigidity and Fasciculations 12
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 11
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 10
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 10
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 9
OUTCOMES AFTER SINGLE-CYCLE RITUXIMAB MONOTHERAPY IN PATIENTS WITH ANTI-MAG ANTIBODY POLYNEUROPATHY: A 11 YEARS FOLLOW-UP ANALYSIS 9
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report 9
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 9
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 8
High-resolution ultrasound and superb microvascular imaging findings in a case of post-COVID-19 vaccine parsonage-turner syndrome with multiple nerves involvement 7
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 7
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome 5
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 4
Cervical alterations in Hirayama disease: an MRI and FDG-PET combined approach 4
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 4
Totale 1.486
Categoria #
all - tutte 7.672
article - articoli 7.672
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.344


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 0 7 6 8 9 16 11 5
2020/2021138 5 18 6 18 8 5 8 17 7 24 12 10
2021/2022169 21 2 0 4 9 13 11 31 23 20 6 29
2022/2023262 17 33 3 31 19 45 5 19 41 6 38 5
2023/2024344 13 18 23 70 17 69 23 29 10 14 16 42
2024/2025458 66 66 28 96 115 87 0 0 0 0 0 0
Totale 1.486